Groups ofpatients with Huntington's disease and probable dementia ofAlzheimer type (DAT) matched for level of dementia on the basis of mini mental state examination scores were compared in several tests of visual memory and tests sensitive to frontal lobe dysfunction.
There is currently much interest in whether dementias arising from different causative factors exhibit qualitatively different patterns of cognitive deficit. This is an issue of some importance, not only in practical terms, but also for understanding the underlying neural substrates of the disorders and the specificity of cognitive deficits over and above generalised intellectual deterioration due to dementia. Previously, Albert et all and Cummings and Benson2 have proposed a distinction between dementia associated with primary subcortical neuropathology (for example, basal ganglia disorders such as Parkinson's and Huntington's diseases) and dementia in which the primary neuropathology is in the association neocortex (for example, dementia of Alzheimer type (DAT)). This distinction between "subcortical" and "cortical" dementia has proved somewhat controversial, not least because clinical rating scales have sometimes failed to support it, but also because the nature of some of the cognitive deficits seen in subcortical dementia may be reminiscent of the symptoms of frontal lobe damage. These are often referred to as examples of executive dysfunction, because they present as problems of planning, attentional set shifting, and slowness of response, rather than the typical signs of posterior cortical damage which lead to such symptoms as aphasia, agnosia, and global amnesia. It was also used and it was possible to match patients according to a premorbid index of IQ.22 To gauge the absolute levels of impairment in the Huntington's disease and DAT groups we have also provided data for separate large groups of normal controls matched as far as possible for age and premorbid estimates of verbal IQ to the DAT and Huntington's disease groups. As might be expected from the recent standardisation21 of much of the CANTAB battery, the performance of the younger control group was slightly superior to that of the older group on certain tests. Whereas this might affect the relative degree of age related impairment between the Huntington's disease and DAT groups, it could not account for any inferior levels of executive performance in the Huntington's disease group in the hypothesis under test. Therefore, for the purposes of this study we focused on a direct comparison of the performance of the two patient groups.
Methods

SUBJECTS
Consecutively presenting patients with Huntington's disease or mild or moderate probable DAT were assessed. In all, 17 patients with probable DAT and 13 with Huntington's disease were tested. Complete data were only obtained on 13 (83%) patients with DAT and 10 (77%) patients with Huntington's disease, because of fatigue and lack of comprehension of the instructions on some tests. As most patients with DAT were primarily in the early stages of the disease with mainly mild symptoms, it was feasible to match the two groups for level of dementia, as assessed with a clinical rating scale (see later).
Patients with dementia of the Alzheimer's type
All thirteen patients attended the Maudsley
Hospital and all were seen on an outpatient basis through the memory clinic.24 Patients were assessed and diagnosed by a consultant psychiatrist in concordance with a second psychiatrist as having DAT following criteria outlined for "probable Alzheimer's disease" Patients with Huntington's disease Ten patients with Huntington's disease were included in the study. The diagnosis was based on personality or intellectual change, together with the presence of chorea or the typical impairment of voluntary movement. These symptoms were not present at birth, were insidious in onset, had gradually become worse, and were associated with a definite family history of at least one other member with these characteristic neurological symptoms and signs. At the time of investigation, the severity of the hyperkinetic involuntary movements was rated according to the chorea scale of the quantified neurological examination, on a scale ranging from 0 to 25 points28; this patient group scored a mean of (SEM 1 1). None of the patients had significantly impaired visual acuity or hearing. At the time of the study, the patients did not exhibit acute confusion or acute psychosis and were not receiving any medication known to affect the CNS. Informed consent was obtained from all patients participating in the study.
Controls
The main purpose of the study was explicitly to compare patients with Huntington's disease and those with DAT. To gauge the relative degree of age related impairment, control data for the main dependent variables have been provided from a large group of healthy normal control subjects (table 2) . These were drawn from a large population of volunteers aged between 55 and 69 years from London, Cambridge, and Newcastle-upon-Tyne (North-East Age Research Panel) in the recently published standardisation of many of the tests of the CANTAB battery. The controls had no history of neurological or psychiatric disorder.
MATERIALS AND PROCEDURES
The main testing procedures were taken from the Cambridge neuropsychological test automated battery (CANTAB), a series of computerised paradigms run on an Acorn BBC Master microcomputer with a high resolution Microvitec colour monitor and a Microvitec (Touchtech 501) touch sensitive screen. The general rationale and utility of the battery for clinical investigations has recently been explained in some detail.29 Subjects were seated roughly 0 5 m from the monitor and it was explained that they would have to respond to stimuli by touching the screen. They were introduced to the apparatus by way of a sensorimotor screening task in which they were asked to respond to a series of flashing crosses on the screen by placing the index finger of their preferred hand on the centre point of each cross. The finger had to be held in place for six seconds at which time another cross appeared. After a short demonstration series in which three consecutive crosses were touched, subjects were presented with a series of 10 crosses to touch at six second intervals. Measures were taken of the latency to point (to the nearest 0-01 s) and the accuracy of the initial pointing contact with the screen (computed in terms of vectorial displacement from the centre of the cross in arbitrary units based on X-Y co-ordinates). No subjects were excluded on the basis of their deficient performance on this task. Spatial working memory task"-In this task the subject was required to search through spatial arrays of boxes to find tokens. Importantly, once a blue token had been found within a particular box, then that box would never be used to hide another token. On each trial, the total number of blue tokens to be found corresponded to the number of boxes on the screen as every box was used just once.
Errors were scored according to the number of occasions on which a subject returned to open a box in which a blue counter had already been found. After four practice trials with three boxes, there were four test trials with each of four, six, and finally eight, boxes. The patient groups were compared in terms of the total number of errors summed across the 12 test trials.
Planning task-This is a modification of the Tower of London task" in which the subject has to move coloured "balls" on the screen from an initial arrangement to one corresponding to the goal arrangement shown in the top half of the screen, as described in detail previously. '5 The starting position of the balls was varied such that in any particular trial the solution could only be reached after a minimum of two, three, four, or five moves. Subjects were instructed to examine the position of the balls at the beginning of each problem and attempt to solve it in the minimum possible number of moves. This was both given to them verbally and displayed on the screen throughout each trial. They were encouraged not to make the first move until they were confident that they could execute the entire sequence needed to solve the problem. The maximum moves allowed corresponded to twice the minimum number possible plus one, or plus two in the case of "five move" problems. The For the attentional set shifting task, the data for the numbers of subjects passing or failing each stage of the test were cast into contingency tables and analysed by the likelihood ratio method.34 35 This method is particularly useful (a) for analysing data with small cell frequencies, as occurs in some of the data to be presented, and (b) for partitioning inhomogeneities in the contingency table by additive, orthogonal contrasts. The resulting "information" statistic (2i) is distributed as x2. 
Results
COMPARISON WITH MATCHED CONTROL GROUPS
For all the measures to be described, both patients with Huntington's disease and those with DAT were significantly worse than their respective control groups of normal volunteers with comparable ages and premorbid estimated IQ (using the national adult reading test (NART); table 2).
SENSORIMOTOR SCREENING TEST
The two groups did not differ significantly on either of the two indices of performance, latency and accuracy of pointing (table 3) .
VISUAL MEMORY AND LEARNING (TABLE 3) The patients with Huntington's disease were significantly worse on both tests of pattern and spatial recognition memory. The patients with Huntington's disease were also worse on simultaneous matching to sample, but the difference disappeared during the delay conditions (0, 4, 8, 16 seconds and retest at zero seconds), although, as expected, performance declined significantly over the delays for the two groups overall (F(3,63) = 9-84, P < 0 001 (table 3) .
Spatial working memory Figure 1 shows that the patients with Huntington's disease committed significantly more between and within search errors in this task (F(1,21) = 10-03, P < 0 005). There was also a significant patient group x set size interaction (F(3,63) = 5 09, P < 0 005) as the difference between the groups only emerged after the difficulty level of three boxes.
Tower of London test
The analyses concentrated on three measures of accuracy for the first block of problems. Figure 2 shows that the patients with Huntington's disease were significantly worse in terms of "perfect solutions" at each stage of difficulty (across two, three, and four move problems) (main effect of patient group, t(2 1) = 3-08, P < 0-001 
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Visual discriminationlattentional set shifting test Figure 3 shows that the patients with Huntington's disease performed significantly worse at the series of visual discriminations. )AT that the neural substrates of many of the cognitive deficits in Huntington's disease are centred on the caudate nucleus3638 but that additional cortical atrophy may also be significant. 37 The neural specificity of the three main cognitive tests may be gauged from the fact that the Tower of London task is insensitive to temporal lobe excisions and amygdalohippocampectomy,'9 as well as more generally to 
s disease have a degree of neural specificity, consistent with the existence of greater frontostriatal pathology in Huntington's disease than in DAT.
The inferior performance of patients with Huntington's disease was not limited to tests clearly requiring executive function, as they were also significantly impaired relative to patients with DAT in tests of perceptual matching to sample, a visual pattern recognition task, a spatial recognition task, spatial span, and in learning sets of visuospatial paired associates. Performance on a difficult visual delayed matching to sample task was also impaired relative to controls, but not to a greater extent than for patients with DAT. Similar results have been reported for patients late in the course of Parkinson's disease'839 possibly due to additional pathology that may affect functioning in cortical regions other than the prefrontal cortex, such as the temporal lobe. The greater magnitude of these deficits in Huntington's disease than in DAT, however, suggests an alternative (though not mutually incompatible) possibility, that the late cognitive deficits in Parkinson's disease and Huntington's disease reflect pathology of the striatum, most likely the caudate nucleus.
Before comparing these results with others, obvious explanations of the differences should be considered. Although the patients with Huntington's disease and those with DAT differed in age, the greater deficits in the case of the Huntington's disease group cannot be artefacts of relative impairments produced by age related changes in the normal population, as the Huntington's disease group was younger and control performance on these tests usually deteriorates slightly with age. Nor can it be said that the patients with Huntington's disease were globally impaired on all tests. Thus accuracy was apparently equivalent in delayed matching to sample for patients with Huntington's disease and DAT when visual patterns had to be retained over a short delay. The two groups were carefully matched for degree of dementia using Folstein' Brandt and Bylsma5) , as the data presented here imply. It was nevertheless interesting to find that the patients with Huntington's disease were more impaired in some of the tests of visual memory and learning such as pattern and spatial recognition, and visuospatial paired associates learning than the patients with DAT, although the reverse was the case for the Kendrick object learning test, which involves the verbal recall of pictures of everyday objects. The relative impairment in pattern and spatial recognition memory in Huntington's disease may seem to contradict earlier results,40 but the patients with Huntington's disease and those with DAT were not explicitly matched for degree of dementia in that earlier study. Moreover, the relative impairment in pattern recognition memory in Huntington's disease was not found in the related test of delayed matching to sample. The impairment in simultaneous matching to sample in the Huntington's disease group relative to DAT, supports the finding of visual perceptual impairments underlying naming deficits. 49 The difference is also reminiscent of other impairments in this test that we have reported in patients with basal ganglia disorders, compared with sparing in mild DAT. 18 39 The relatively novel feature of the present study is its focus on tests sensitive to executive control over performance and to frontal lobe dysfunction, aspects of cognition in Huntington's disease that have been the subject of only a few investigations. Impairments at this early stage of the test are not necessarily hallmarks of frontal lobe (or executive) dysfunction. In anatomical terms, whereas reversal learning in animals is impaired by damage to the medial orbitofrontal cortex5" and the region of the striatum to which it projects,54 such deficits are also known to occur-for example, after damage to the amygdala.55 A more telling piece of evidence was that the performance of patients with Huntington's disease, unlike those with DAT was very perseverative in nature, possibly implicating dysfunction of the orbitofrontal cortex and associated outflow via the caudate nucleus. Jones and Mishkin5" found that lesions to the orbitofrontal cortex produced just this form of deficit in monkeys, whereas lesions to the amygdala produced more pervasive deficits in learning new stimulusreward associations. There is evidence that this form of perseveration in reversal learning may be distinct from failures to shift attentional set at the extradimensional shift stage,55 which we have found to be a sensitive indicator of cognitive impairment in patients early in the course of Huntington's disease (unpublished findings), as well as in other forms of basal ganglia disease, including Parkinson's disease, Steele-Richardson-Olsewski syndrome, and multiple system atrophy. '6 17 Other forms of perseveration, such as occur in tests of verbal fluency, are not apparently a major feature of Huntington's disease.5 The Huntington's disease deficit in visual discrimination reversal learning is of further theoretical interest because it can be viewed as a difficulty in learning new stimulus-response habits, theorised by some authors56 to be an expression of the procedural learning that has been postulated to form part of the function of structures within the basal ganglia. It seems, however, that the deficit is not so much one of acquiring new visual habits, as of inhibiting previously acquired ones.
The impairments in spatial working memory were also consistent with a pronounced propensity for perseveration, as the number of between search errors (inappropriately returning to a previously successful choice) was very high, as great numerically as in any other disorder we have examined, including frontal lobe damage. This perseverative tendency was also manifest in terms of repeated, although ineffective, responses within a search sequence (within search errors). Studies with groups of neurosurgical patients with frontal lobe lesions1I and other groups with basal ganglia disease'6 17 as well as experimental animals in directly analogous tasks55 support the view that the pattern of performance on this task most likely reflects dysfunction of frontostriatal circuitry.
It was hardly surprising to find planning performance in Huntington's disease to be severely affected, given that component capacities, such as spatial span and spatial working memory were themselves so severely impaired. The deficit in planning was manifest even on the easy problems (for example, "two movers"), although extensive practice 
